Calysta wins global award for protein innovation

Friday, 23 September 2016

Menlo Park, CA - (September 23, 2016) - Calysta’s FeedKind® protein, a new fish and animal feed ingredient, has been named as the Most Disruptive Innovation at the Bridge2Food Protein Awards.

The award, presented at the 9th Protein Summit in Lille, France, comes just days after Calysta officially opened its market introduction facility to produce FeedKind in Teesside, England.

Dr. Alan Shaw, Calysta President and CEO, said: “We’re extremely pleased to have achieved this global accolade that recognises our proprietary technology as a game-changing innovation.

“With FeedKind, Calysta has an exciting opportunity to offer traceable and safe protein that will sustainably help feed the world for decades to come.”

Calysta has partnered with Cargill for production of FeedKind protein in North America and entered into a global joint marketing agreement. A global production facility is expected to open in the United States within two years.

Member of the judging panel, Dr. Anne Wagner, Corporate Research & Development Director at Tereos, said: “We felt that we needed to award an innovation which is truly disruptive both from a technological point of view and also one that identifies alternative sources of protein to meet the protein demands of a growing population”.

Located in the Netherlands, Bridge2Food is a research group that supports international organisations and businesses in the food and animal feed industries in relation to protein ingredients

About Calysta

Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable products. Calysta Nutrition develops and commercialises fish and livestock nutritional products improving food security worldwide.

Press Contacts

Mhairi Greer 07976 443626 This email address is being protected from spambots. You need JavaScript enabled to view it.

Lyn Christenson 650.492.6880 This email address is being protected from spambots. You need JavaScript enabled to view it.

Calysta Media Information This email address is being protected from spambots. You need JavaScript enabled to view it.